NCT00236821View on ClinicalTrials.gov

A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia

PHASE3CompletedINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

June 30, 2002

Conditions
Pneumonia
Interventions
DRUG

levofloxacin

All Listed Sponsors
collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236821 - A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia | Biotech Hunter | Biotech Hunter